Use of terlipressin in critically ill children with liver disease

BMC Nephrology

Table 3 Profile of Terlipressin usage for HRS-AKI patients^a

Parameter	HRS n = 7 pts (9 patient records)	Non HRS n = 9 pts (15 patient records)	p value
Renal angina index	10 (1–10)	5 (5–8)	0.06
Creatinine 0 h^b	84 (48–116)	67 (38–78)	0.43
Creatinine 12 h^b	36 (30–120)	70 (48–108)	0.53
Creatinine 24 h^b	36 (17–41)	58.5 (33–89.5)	0.39
Creatinine 48 h^b	29 (22–30)	71 (37–96.5)	0.32
Creatinine 7 days^b	28 (23–29)	65.5 (25–85.5)	0.32
Urine output 0 hb^c	0.6 (0–1.1)	0.1 (0–4)	0.43
Urine output 6 hb^c	2.6 (0.2–5.0)	0.2 (0–1.9)	0.1
Urine output 12 hb^c	1.5 (0–3.0)	0 (0–1)	0.392
Urine output 24 hb^c	0.9 (0–1.8)	0.3 (0–1.7)	0.42
Urine output 48 h^cb	3 (0–3)	2 (0–2)	0.029
Urine output 7 daysb^c	2 (0–2)	3 (0–4)	0.306
Sodium 0 h^dc	141 (136–152)	138 (135–139)	0.202
Sodium 12 h^dc	150.5 (143–158)	136.4 (134.6–139)	0.191
Sodium 24 h^dc	143 (137.5–155)	137 (135–138)	0.259
Sodium 48 h^dc	138 (135–139)	140 (136–144)	0.354
Sodium 7 daysc^d	138 (137–138)	138 (137–142)	0.696
Mortality	40%	50%	0.55

^apatient administration records; ^bexpressed as (median)(IQR); Cr Creatinine expressed in μmol/L;^cb in ml/kg/hr.; ^dc in meq/litre

ISSN: 1471-2369